D-β-hydroxybutyrate ester is a ‘ketone body’ which are produced by the body during periods of limited glucose availability such as during intense and prolonged physical exertion. The applicant suggests that consumption of D-β-hydroxybutyrate ester during periods of intense exercise will maintain physical and cognitive performance and is proposing its use in food supplements that will be used exclusively by high performance athletes.
D-β-hydroxybutyrate ester is a novel food and before any new food product can be introduced on the European market, it must be rigorously assessed for safety. In the UK, the assessment of novel foods is carried out by an independent committee of scientists appointed by the Food Standards Agency, the Advisory Committee on Novel Foods and Processes (ACNFP). Any claims that may be made for D-β-hydroxybutyrate ester will require approval under EU nutrition and health claims legislation.
Any comments on this application should be sent to the ACNFP Secretariat by 20 October 2013 and will be passed to the Committee during its assessment of this novel food ingredient. Please note that appendices are available on request.
All views/comments received by the Agency will be made available for public examination. If you would prefer your comments NOT to be made publicly available, please indicate this by fully completing and returning the data protection form (attached below) together with your response.